B. V. Subba Reddy et al. / Tetrahedron Letters 53 (2012) 2396–2401
2401
8. (a) Palomo, C.; Aizpurua, J. M.; Ganboa, I.; Oiarbide, M. Eur. J. Org. Chem. 1999,
3223; (b) Dürkheimer, W.; Blumbach, J.; Lattrell, R.; Scheunemann, K. H. Angew.
Chem., Int. Ed. 1985, 24, 180; (c) Morin, R. B.; Gorman, M. In Chemistry and
Biology of b-Lactam Antibiotics; Academic Press: New York, 1982; Vol. 123,; (d)
Southgate, R; Branch, C.; Coulton, S.; Hunt, E. In Recent Progress in the Chemical
Synthesis of Antibiotics and Related Microbial Products; Lukacs, G., Ed.; Springer-
Verlag: Berlin, 1993; Vol. 2, p 621.
9. General procedure: A mixture of isatin-3-arylimine (1 mmol) and rhodium(II)
acetate (5 mol %) was stirred in dry dichloromethane (10 mL). A solution of diazo
compound (1.2 mmol) in dry dichloromethane (2 mL) was added drop wise over
15 min. The resulting mixture was stirred under reflux for a specified time (Table
1). After completion, as indicated by TLC, the solvent was removed under reduced
pressure and the resulting residue was purified by column chromatography on
silica gel using n-hexanes/EtOAc (8/2) as eluent to afford the product 3. In case of
b-lactam synthesis, the product was eluted with n-hexanes/EtOAc (3/1). All the
products were characterized by IR, NMR and mass spectral data.
2.02 (s, 3H), 2.23 (s, 3H), 3.97 (dd, J = 5.1, 11.3 Hz, 1H), 4.31 (dd, J = 4.7, 11.8 Hz,
1H), 4.78 (d, J = 17.1 Hz, 1H), 5.04 (d, J = 10.3 Hz, 1H), 5.52 (m, 1H), 6.52 (d,
J = 7.7 Hz, 1H), 6.78 (m, 2H), 6.98 (m, 3H), 7.24 (m, 1H), 7.55 (d, J = 7.3 Hz, 1H); 13
C
NMR (75 MHz, CDCl3): d 10.3, 17.5, 21.0, 42.1, 89.6, 105.0, 109.9, 117.4, 123.4,
124.9, 126.1, 129.2, 129.6, 130.0, 131.6, 133.8, 138.0, 142.1, 158.7, 164.01, 169.7;
IR (KBr): mmax 2919, 1742, 1659, 1607, 1469, 1394, 1355, 1270, 1186, 1120,
762 cmꢀ1; HRMS (ESI) calcd for C23H23N2O3 [M+H]: 375.1708, found: 375.1723.
Methyl-10,3-dimethyl-20,4-dioxo-1-(p-tolyl)spiro[azetidine-2,30-indoline]-3-
carboxylate (5c): Colourless solid, mp 183–184 °C; 1H NMR (400 MHz, CDCl3): d
1.77 (s, 3H), 2.24 (s, 3H), 3.35 (s, 3H), 3.60 (s, 3H), 7.01 (m, 6H), 7.26 (m, 1H), 7.44
(m, 1H); 13C NMR (100 MHz, CDCl3): d 13.7, 20.8, 26.9, 52.3, 66.8, 68.9, 109.1,
117.1, 122.2, 123.0, 124.1, 129.7, 131.1, 133.2, 134.5, 143.7, 162.9, 168.8, 171.6; IR
(KBr): mmax 2978, 2936, 1767, 1722, 1613, 1513, 1465, 1390, 1249, 1135, 1087,
1023, 826, 759 cmꢀ1; HRMS (ESI) calcd for C21H20N2O4Na: 387.1320, found:
387.1317.
Methyl-10-allyl-3-methyl-20,4-dioxo-1-phenylspiro[azetidine-2,30-indoline]-3-
carboxylate (5e): Colourless solid, mp 153–155 °C; 1H NMR (400 MHz, CDCl3): d
1.83 (s, 3H), 3.59 (s, 3H), 4.35 (dd, J = 4.0, 12.0 Hz, 1H), 4.57 (dd, J = 4.0, 12.0 Hz,
1H), 5.27 (m, 2H), 5.89 (m, 1H), 6.96 (d, J = 8.0 Hz, 1H), 7.09 (m, 4H), 7.26 (m, 3H),
7.41 (m, 1H); 13C NMR (100 MHz, CDCl3): d 13.8, 45.6, 52.4, 66.8, 69.0, 110.0,
117.1, 117.9, 122.1, 122.9, 124.1, 124.7, 129.2, 130.6, 131.0, 136.2, 142.8, 163.1,
The spectral data of the selected products: 1,50,60-trimethyl-30-phenylspiro
[indoline-3,20-[1,3]oxazine]-2,40(30H)-dione (3a): Colourless solid, mp 189–
192 °C; 1H NMR (400 MHz, CDCl3): d 1.95 (s, 3H), 2.03 (s, 3H), 3.04 (s, 3H), 6.73
(d, J = 8.0 Hz, 1H), 6.94 (m, 2H), 7.17 (m, 3H), 7.35 (t, J = 8.0 Hz, 1H), 7.57 (d,
J = 8.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 10.3, 17.5, 26.2, 89.5, 105.1, 109.0,
123.5, 125.0, 125.8, 128.0, 128.9, 128.9, 131.7, 136.8, 142.9, 158.7, 164.1, 170.0; IR
(KBr): mmax 2932, 1728, 1674, 1610, 1471, 1392, 1347, 1245, 1178, 1086, 762,
692 cmꢀ1; HRMS (ESI) calcd for C20H19N2O3 [M+H]: 335.1395, found: 336.1388.
1-Benzyl-50,60-dimethyl-30-phenylspiro[indoline-3,20-[1,3]oxazine]-2,40(30H)-dione
(3b): Colourless solid, mp 179–182 °C; 1H NMR (400 MHz, CDCl3): d 1.99 (s, 3H),
2.07 (s, 3H), 4.45 (d, J = 16.0 Hz, 1H), 5.05 (d, J = 16.0 Hz, 1H), 6.59 (m, 1H), 6.80
(m, 2H), 7.00 (m, 1H), 7.28 (m, 7H), 7.65 (d, J = 7.6 Hz, 1H); 13C NMR (100 MHz,
CDCl3): d 10.3, 17.6, 43.8, 89.7, 105.1, 110.2, 123.6, 124.8, 126.2, 126.9, 127.6,
128.2, 128.77, 129.17, 129.7, 131.7, 134.4, 136.5, 142.0, 158.9, 164.0, 169.8; IR
168.6, 171.2; IR (KBr):
m
max 2930, 1768, 1731, 1605, 1499, 1380, 1277, 1188, 1137,
946, 751, 687 cmꢀ1
399.1338.
; HRMS(ESI) calcd for C22H20N2O4Na: 399.1320, found:
Methyl-10-allyl-3-methyl-20,4-dioxo-1-(p-tolyl)spiro[azetidine-2,30-indoline]-3-
carboxylate (5f): Colourless solid, mp 130–133 °C; 1H NMR (300 MHz, CDCl3): d
1.71 (s, 3H), 2.23 (s, 3H), 3.56 (s, 3H), 4.32 (dd, J = 4.9, 11.5 Hz, 1H), 4.53 (dd,
J = 5.1, 11.3 Hz, 1H), 5.27 (m, 2H), 5.88 (m, 1H), 6.88 (m, 3H), 6.99 (m, 3H), 7.23 (m,
1H), 7.34 (m, 1H); 13C NMR (75 MHz, CDCl3): d 13.8, 20.8, 42.7, 52.4, 66.8, 68.9,
110.0, 117.1, 117.9, 122.2, 122.9, 124.0, 129.6, 130.6, 131.0, 133.7, 134.5, 142.8,
162.9, 168.7, 171.3; IR (KBr): mmax 2929, 1769, 1728, 1611, 1515, 1377, 1275,
1175, 1133, 754, 701 cmꢀ1; HRMS(ESI) calcd for C23H22N2O4Na: 413.1477, found:
413.1497.
(KBr): m ;
max 2926, 1724, 1666, 1608, 1462, 1396, 1356, 1288, 1182, 744, 692 cmꢀ1
HRMS (ESI) calcd for C26H23N2O3 [M+H]: 411.1708, found: 411.1727.
1-Allyl-50,60-dimethyl-30-(p-tolyl)spiro[indoline-3,20-[1,3]oxazine]-2,40(30H)-dione
(3f): Colourless solid, mp 131–133 °C; 1H NMR (300 MHz, CDCl3): d 1.92 (s, 3H),